Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells.

María Antonia Baltrons1, Carlos E Pedraza, Michael T Heneka

  • 1Instituto de Biotecnología y Biomedicina V. Villar Palasi, Departamento de Bioquímica Biología Molecular, Universidad Autónoma de Barcelona, 08193, Bellaterra, Spain.

Neurobiology of Disease
|July 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human IL-34 Deficiency Primes Microglia Toward Alzheimer's Disease-Associated States.

medRxiv : the preprint server for health sciences·2026
Same author

Landscape of copy number variants in Spanish people with dementia.

NPJ genomic medicine·2026
Same author

Neuroinflammation and neurodegeneration trigger a specific splice form of ribosomal protein S24.

Brain : a journal of neurology·2026
Same author

MOLT: multi-object and lineage tracking in 2D and 3D biomedical time-series imaging.

BMC bioinformatics·2026
Same author

Inflammasome adaptor ASC promotes sustained neuroinflammation and mild cognitive impairment in a closed-head injury model.

The Journal of clinical investigation·2026
Same author

Longitudinal Monitoring of Brain Volume Changes After COVID-19 Infection Using Artificial Intelligence-Based MRI Volumetry.

Diagnostics (Basel, Switzerland)·2025

Beta-amyloid peptides decrease cyclic GMP accumulation in astrocytes by reducing soluble guanylyl cyclase (sGC) expression. This effect is independent of nitric oxide and suggests a mechanism to regulate signaling in reactive astrocytes.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Beta-amyloid peptides (betaA) are implicated in astroglial cell reactivity and nitric oxide (NO) synthase expression.
  • Astroglial cells play crucial roles in brain function and disease pathology.

Purpose of the Study:

  • To investigate the impact of beta-amyloid on cyclic GMP (cGMP) accumulation in astrocytes.
  • To determine the role of nitric oxide (NO) and soluble guanylyl cyclase (sGC) in beta-amyloid-induced changes in astrocytes.

Main Methods:

  • Treatment of rat brain astrocytes with beta-amyloid peptides.
  • Measurement of cGMP accumulation in response to NO.
  • Analysis of soluble guanylyl cyclase (sGC) protein and mRNA expression.
  • Intracerebral injection of beta-amyloid in adult rats.

Related Experiment Videos

  • Inhibition of NO synthase and protein synthesis.

    • Main Results:

    • Beta-amyloid treatment decreased astrocyte capacity to accumulate cGMP in response to NO.
    • This decrease was attributed to reduced expression of soluble guanylyl cyclase (sGC) at both protein and mRNA levels.
    • Nitric oxide was not involved in the down-regulation of sGC.
    • The effect of beta-amyloid on sGC was prevented by cycloheximide, indicating a requirement for protein synthesis.
    • Intracerebral beta-amyloid injection reduced sGC beta1 subunit mRNA levels in vivo.

    Conclusions:

    • Beta-amyloid peptides reduce soluble guanylyl cyclase (sGC) expression in astrocytes, impairing cGMP signaling.
    • This mechanism is independent of nitric oxide and involves de novo protein synthesis.
    • Loss of sGC in reactive astrocytes near amyloid plaques may prevent excessive cGMP signaling in areas of high NO production.